|  Help  |  About  |  Contact Us

Publication : SETD4-mediated KU70 methylation suppresses apoptosis.

First Author  Wang Y Year  2022
Journal  Cell Rep Volume  39
Issue  6 Pages  110794
PubMed ID  35545041 Mgi Jnum  J:326401
Mgi Id  MGI:7284671 Doi  10.1016/j.celrep.2022.110794
Citation  Wang Y, et al. (2022) SETD4-mediated KU70 methylation suppresses apoptosis. Cell Rep 39(6):110794
abstractText  The mammalian KU70 is a pleiotropic protein functioning in DNA repair and cytoplasmic suppression of apoptosis. We report a regulatory mechanism by which KU70's cytoplasmic function is enabled due to a methylation at K570 of KU70 by SET-domain-containing protein 4 (SETD4). While SETD4 silencing reduces the level of methylated KU70, over-expression of SETD4 enhances methylation of KU70. Mutations of Y272 and Y284 of SETD4 abrogate methylation of KU70. Although SETD4 is predominantly a nuclear protein, the methylated KU70 is enriched in the cytoplasm. SETD4 knockdown enhances staurosporine (STS)-induced apoptosis and cell killing. Over-expression of the wild-type (WT) SETD4, but not the SETD4-Y272/Y284F mutant, suppresses STS-induced apoptosis. The KU70-K570R (mouse Ku70-K568R) mutation dampens the anti-apoptosis activity of KU70. Our study identifies KU70 as a non-histone substrate of SETD4, discovers a post-translational modification of KU70, and uncovers a role for SETD4 and KU70-K570 methylation in the suppression of apoptosis.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

4 Bio Entities

Trail: Publication

0 Expression